
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas
Amy Jamieson, Lisa Vermij, Claire J.H. Kramer, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 23, pp. 4949-4957
Open Access | Times Cited: 20
Amy Jamieson, Lisa Vermij, Claire J.H. Kramer, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 23, pp. 4949-4957
Open Access | Times Cited: 20
Showing 20 citing articles:
Targeted and Shallow Whole-Genome Sequencing Identifies Therapeutic Opportunities in p53abn Endometrial Cancers
Amy Jamieson, Juliana Sobral de Barros, Dawn R. Cochrane, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 11, pp. 2461-2474
Open Access | Times Cited: 7
Amy Jamieson, Juliana Sobral de Barros, Dawn R. Cochrane, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 11, pp. 2461-2474
Open Access | Times Cited: 7
Endometrial carcinoma: 10 years of TCGA (the cancer genome atlas): A critical reappraisal with comments on FIGO 2023 staging
Íñigo Espinosa, Emanuela D’Angelo, Jaime Prat
Gynecologic Oncology (2024) Vol. 186, pp. 94-103
Closed Access | Times Cited: 7
Íñigo Espinosa, Emanuela D’Angelo, Jaime Prat
Gynecologic Oncology (2024) Vol. 186, pp. 94-103
Closed Access | Times Cited: 7
Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasion
Amy Jamieson, Marcel Grube, Samuel Leung, et al.
International Journal of Gynecological Cancer (2024) Vol. 34, Iss. 4, pp. 544-549
Open Access | Times Cited: 6
Amy Jamieson, Marcel Grube, Samuel Leung, et al.
International Journal of Gynecological Cancer (2024) Vol. 34, Iss. 4, pp. 544-549
Open Access | Times Cited: 6
Impact of molecular classification on recurrence risk in endometrial cancer patients with lymph node metastasis: multicenter retrospective study
Gabriella Schivardi, Giuseppe Caruso, Luigi Antonio De Vitis, et al.
International Journal of Gynecological Cancer (2024) Vol. 34, Iss. 10, pp. 1561-1569
Closed Access | Times Cited: 5
Gabriella Schivardi, Giuseppe Caruso, Luigi Antonio De Vitis, et al.
International Journal of Gynecological Cancer (2024) Vol. 34, Iss. 10, pp. 1561-1569
Closed Access | Times Cited: 5
Challenging the Binary Classification of Endometrioid Endometrial Adenocarcinoma: The Evaluation of Grade 2 as an Independent Entity Based on Prognostic Characteristics and Recurrence Patterns
Andreas Zouridis, Ammara Kashif, Ahmed Darwish, et al.
Cancers (2025) Vol. 17, Iss. 1, pp. 127-127
Open Access
Andreas Zouridis, Ammara Kashif, Ahmed Darwish, et al.
Cancers (2025) Vol. 17, Iss. 1, pp. 127-127
Open Access
Relapse Frequency and Pattern Following Adjuvant Radiotherapy for Intermediate and High-Intermediate Risk Endometrial Cancer Based on Retrospective ESGO-ESTRO-ESP Risk Classification
Kathryn Graham, Laura Hannington, Claire Duncanson, et al.
Clinical and Experimental Obstetrics & Gynecology (2025) Vol. 52, Iss. 2
Open Access
Kathryn Graham, Laura Hannington, Claire Duncanson, et al.
Clinical and Experimental Obstetrics & Gynecology (2025) Vol. 52, Iss. 2
Open Access
Low-Grade Endometrial Cancer with Abnormal p53 Expression as a Separate Clinical Entity: Insights from RNA Sequencing and Immunohistochemistry
Kazuhisa Hachisuga, Minoru Kawakami, Hiroshi Tomonobe, et al.
Diagnostics (2025) Vol. 15, Iss. 6, pp. 671-671
Open Access
Kazuhisa Hachisuga, Minoru Kawakami, Hiroshi Tomonobe, et al.
Diagnostics (2025) Vol. 15, Iss. 6, pp. 671-671
Open Access
The New 2023 Endometrial Cancer FIGO Staging System: Balancing Innovation with Complexity
Emilia Palmieri, Andrea Mariani, Robert L. Coleman, et al.
International Journal of Gynecological Cancer (2025), pp. 101823-101823
Closed Access
Emilia Palmieri, Andrea Mariani, Robert L. Coleman, et al.
International Journal of Gynecological Cancer (2025), pp. 101823-101823
Closed Access
Assessment of p53 in Endometrial Carcinoma Biopsy and Corresponding Hysterectomy Cases in a Real-World Setting: Which Cases Need Molecular Work-Up?
Marie‐Lisa Eich, Janna Siemanowsk-Hrach, Uta Drebber, et al.
Cancers (2025) Vol. 17, Iss. 9, pp. 1506-1506
Open Access
Marie‐Lisa Eich, Janna Siemanowsk-Hrach, Uta Drebber, et al.
Cancers (2025) Vol. 17, Iss. 9, pp. 1506-1506
Open Access
Serum CA125 levels in the context of ProMisE molecular classification provides pre-operative prognostic information that can direct endometrial cancer management
Andrea Neilson, Amy Jamieson, Derek S. Chiu, et al.
Gynecologic Oncology (2024) Vol. 193, pp. 1-11
Open Access | Times Cited: 2
Andrea Neilson, Amy Jamieson, Derek S. Chiu, et al.
Gynecologic Oncology (2024) Vol. 193, pp. 1-11
Open Access | Times Cited: 2
Molecular pathology of endometrial cancer: recent advances in classification, prognostication, and management
Mona Alfaraidi, Jutta Huvila, C. Blake Gilks
Diagnostic histopathology (2024) Vol. 30, Iss. 9, pp. 499-510
Closed Access | Times Cited: 1
Mona Alfaraidi, Jutta Huvila, C. Blake Gilks
Diagnostic histopathology (2024) Vol. 30, Iss. 9, pp. 499-510
Closed Access | Times Cited: 1
RB Loss in p53 Abnormal Endometrial Carcinoma: Histological and Clinicopathological Correlates
Ezgi Dicle Serbes, Nanda Horeweg, Carlos Parra‐Herran, et al.
Modern Pathology (2024), pp. 100660-100660
Open Access | Times Cited: 1
Ezgi Dicle Serbes, Nanda Horeweg, Carlos Parra‐Herran, et al.
Modern Pathology (2024), pp. 100660-100660
Open Access | Times Cited: 1
Response: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer—FIGO 2023 classification
David G. Mutch, David K. Gaffney, Xavier Matías‐Guiu, et al.
International Journal of Gynecology & Obstetrics (2024) Vol. 165, Iss. 3, pp. 1304-1305
Closed Access
David G. Mutch, David K. Gaffney, Xavier Matías‐Guiu, et al.
International Journal of Gynecology & Obstetrics (2024) Vol. 165, Iss. 3, pp. 1304-1305
Closed Access
Range of Resection in Endometrial Cancer—Clinical Issues of Made-to-Measure Surgery
Agnieszka Horała, Sebastian Szubert, Ewa Nowak‐Markwitz
Cancers (2024) Vol. 16, Iss. 10, pp. 1848-1848
Open Access
Agnieszka Horała, Sebastian Szubert, Ewa Nowak‐Markwitz
Cancers (2024) Vol. 16, Iss. 10, pp. 1848-1848
Open Access
Molecular classification of metastatic and recurrent endometrial endometrioid carcinoma: prognostic relevance among low‐ and high‐stage tumours
Austin McHenry, Kelly A. Devereaux, Emily Ryan, et al.
Histopathology (2024) Vol. 85, Iss. 4, pp. 614-626
Closed Access
Austin McHenry, Kelly A. Devereaux, Emily Ryan, et al.
Histopathology (2024) Vol. 85, Iss. 4, pp. 614-626
Closed Access
Correlation Analysis between Molecular Subtypes of Type I Endometrial Cancer and the Duration of Abnormal Uterine Bleeding-----A Small Sample Size Single Center Retrospective Analysis
YE Yan-li, Xiang Xiao Die, Wang Tian Mei, et al.
(2024)
Closed Access
YE Yan-li, Xiang Xiao Die, Wang Tian Mei, et al.
(2024)
Closed Access
Diabetes mellitus complications associated with recurrence of stage I endometrioid endometrial cancer: A single-center retrospective study
Corrine A. Nief, Sara Long, Tamra-Lee McCleary, et al.
Gynecologic Oncology (2024) Vol. 190, pp. 298-306
Closed Access
Corrine A. Nief, Sara Long, Tamra-Lee McCleary, et al.
Gynecologic Oncology (2024) Vol. 190, pp. 298-306
Closed Access
CD73 restrains mutant β-catenin oncogenic activity in endometrial carcinomas
Rebecca M. Hirsch, Sunthoshini Premsankar, Katherine C. Kurnit, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Rebecca M. Hirsch, Sunthoshini Premsankar, Katherine C. Kurnit, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Initiation of molecular testing of endometrial carcinomas in a population‐based setting: practical considerations and pitfalls
Jesús Machuca‐Aguado, Mark Catherwood, Oisín Houghton, et al.
Histopathology (2024)
Closed Access
Jesús Machuca‐Aguado, Mark Catherwood, Oisín Houghton, et al.
Histopathology (2024)
Closed Access
Low-grade endometrial endometrioid carcinoma of the p53-abnormal group: case presentation and diagnostic issues
Susanna Ronchi, Eleonora Di Lauro, Carla Facco, et al.
Pathologica (2024) Vol. 116, Iss. 5, pp. 320-323
Open Access
Susanna Ronchi, Eleonora Di Lauro, Carla Facco, et al.
Pathologica (2024) Vol. 116, Iss. 5, pp. 320-323
Open Access